Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction

The effect of acute myocardial infarction (AMI) on regional cardiac adrenergic function was studied in 27 patients mean ± standard deviation 10 ± 4 days after AMI. Regional adrenergk function was evaluated noninvasively with I-123 meta-iodobenzylguanidine (MIBG) using a dedicated 3-detector tomograp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 1991-02, Vol.67 (4), p.236-242
Hauptverfasser: McGhie, A.Iain, Corbett, James R., Akers, Marvin S., Kulkarni, Padmakur, Sills, Michael N., Kremers, Mark, Buja, L.Maximilian, Durant-Reville, Marc, Parkey, Robert W., Willerson, James T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 242
container_issue 4
container_start_page 236
container_title The American journal of cardiology
container_volume 67
creator McGhie, A.Iain
Corbett, James R.
Akers, Marvin S.
Kulkarni, Padmakur
Sills, Michael N.
Kremers, Mark
Buja, L.Maximilian
Durant-Reville, Marc
Parkey, Robert W.
Willerson, James T.
description The effect of acute myocardial infarction (AMI) on regional cardiac adrenergic function was studied in 27 patients mean ± standard deviation 10 ± 4 days after AMI. Regional adrenergk function was evaluated noninvasively with I-123 meta-iodobenzylguanidine (MIBG) using a dedicated 3-detector tomograph. Four hours after its administration, there was reduced MIBG uptake in the region of infarction, 0.38 ± 0.31 counts/pixel/mCi × 103 compared with 0.60 ± 0.30 counts/pixel/mCi × 103 and 0.92 ± 0.35 counts/pixel/mCi × 103 in the zones bordering and distant from the infarct area, respectively, p < 0.001. In all patients, the area of reduced MIBG uptake after 4 hours was more extensive than the associated thallium-201 perfusion defect with defect scores of 52 ± 22 and 23 ± 18%, respectively, p < 0.001. After anterior wall AMI, the 4-hour MIBG defect score was 70 ± 13% and the degree of mismatch between myocardial perfusion and MIBG uptake was 30 ± 9% compared with 39 ± 17 and 21 ± 17% after inferior AMI, p < 0.001 and p = 0.016, respectively. The 4-hour MIBG defect score correlated inversely with the predischarge left ventricular ejection fraction, r = −0.73, p < 0.001. Patients with ventricular arrhythmia of ≥1 ventricular premature complexes per hour, paired ventricular premature complexes or ventricular tachycardia detected during the late hospital phase had higher 4-hour MIBG defect scores, 62.5 ± 15.0%, than patients with no detectable complex ventricular ectopic activity and a ventricular premature complex frequency of
doi_str_mv 10.1016/0002-9149(91)90552-V
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_5893962</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000291499190552V</els_id><sourcerecordid>80433943</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-28bfe88eb70b973d20c04210a892d43dba936d6142dedae57d3cbaf50c2926e73</originalsourceid><addsrcrecordid>eNp9kUuLFTEQhYMo452r_0ChERx00ZpHv7IRZPAxMCCIzjZUJ9U9ke7kmqSF68a_bnr6oq5cJCHUd05Spwh5wugrRlnzmlLKS8kq-UKyl5LWNS9v7pEd61pZMsnEfbL7gzwk5zF-y1fG6uaMnDEpadvVO_LrM47WO5gKDcFY0AWYgA7DaHUxLE6nXC2WaN1YXJWMi2LGBKX1xvfofh6ncQFnjXVYJD_7McDhNivtDOMqgSFhKEAvCYv56Lc3psK6AcKd9SPyYIAp4uPTuSdf37_7cvmxvP704ery7XWpBZep5F0_YNdh39JetsJwqmnFGYVOclMJ04MUjWlYxQ0awLo1Qvcw1FRzyRtsxZ4823x9TFZFbRPqW-2dQ51U3UkhG56hiw06BP99wZjUbKPGaQKHfomqo5UQMq89qTZQBx9jwEEdQm45HBWjah2OWpNXa_J5U3fDUTdZ9vTkv_Qzmr-ibRq5_vxUh6hhGgI4beM_WMNExZvMvdk4zIn9sBjWhtBpNDas_Rhv__-R31b8rUw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80433943</pqid></control><display><type>article</type><title>Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>McGhie, A.Iain ; Corbett, James R. ; Akers, Marvin S. ; Kulkarni, Padmakur ; Sills, Michael N. ; Kremers, Mark ; Buja, L.Maximilian ; Durant-Reville, Marc ; Parkey, Robert W. ; Willerson, James T.</creator><creatorcontrib>McGhie, A.Iain ; Corbett, James R. ; Akers, Marvin S. ; Kulkarni, Padmakur ; Sills, Michael N. ; Kremers, Mark ; Buja, L.Maximilian ; Durant-Reville, Marc ; Parkey, Robert W. ; Willerson, James T.</creatorcontrib><description>The effect of acute myocardial infarction (AMI) on regional cardiac adrenergic function was studied in 27 patients mean ± standard deviation 10 ± 4 days after AMI. Regional adrenergk function was evaluated noninvasively with I-123 meta-iodobenzylguanidine (MIBG) using a dedicated 3-detector tomograph. Four hours after its administration, there was reduced MIBG uptake in the region of infarction, 0.38 ± 0.31 counts/pixel/mCi × 103 compared with 0.60 ± 0.30 counts/pixel/mCi × 103 and 0.92 ± 0.35 counts/pixel/mCi × 103 in the zones bordering and distant from the infarct area, respectively, p &lt; 0.001. In all patients, the area of reduced MIBG uptake after 4 hours was more extensive than the associated thallium-201 perfusion defect with defect scores of 52 ± 22 and 23 ± 18%, respectively, p &lt; 0.001. After anterior wall AMI, the 4-hour MIBG defect score was 70 ± 13% and the degree of mismatch between myocardial perfusion and MIBG uptake was 30 ± 9% compared with 39 ± 17 and 21 ± 17% after inferior AMI, p &lt; 0.001 and p = 0.016, respectively. The 4-hour MIBG defect score correlated inversely with the predischarge left ventricular ejection fraction, r = −0.73, p &lt; 0.001. Patients with ventricular arrhythmia of ≥1 ventricular premature complexes per hour, paired ventricular premature complexes or ventricular tachycardia detected during the late hospital phase had higher 4-hour MIBG defect scores, 62.5 ± 15.0%, than patients with no detectable complex ventricular ectopic activity and a ventricular premature complex frequency of &lt;1 per hour, 44.6 ± 23.4%, p = 0.036. These data suggest that after acute AMI in humans (1) the abnormality in adrenergic function is more extensive than the associated abnormality in myocardial perfusion; (2) anterior wall AMI is associated with greater disruption of cardiac adrenergic function than other infarcts; (3) the severity of cardiac adrenergic dysfunction correlates with the degree of left ventricular dysfunction; and (4) the abnormality in regional adrenergic function may be associated with the presence of ventricular ectopic activity after AMI.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/0002-9149(91)90552-V</identifier><identifier>PMID: 1990785</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>3-Iodobenzylguanidine ; 550601 - Medicine- Unsealed Radionuclides in Diagnostics ; Adult ; Aged ; Arrhythmias, Cardiac - complications ; BETA DECAY RADIOISOTOPES ; Biological and medical sciences ; BIOMEDICAL RADIOGRAPHY ; BODY ; Cardiology. Vascular system ; CARDIOVASCULAR DISEASES ; CARDIOVASCULAR SYSTEM ; Catecholamines - blood ; COMPUTERIZED TOMOGRAPHY ; Contrast Media ; Coronary heart disease ; DIAGNOSIS ; DIAGNOSTIC TECHNIQUES ; DISEASES ; ELECTRON CAPTURE RADIOISOTOPES ; EMISSION COMPUTED TOMOGRAPHY ; Female ; HEART ; HOURS LIVING RADIOISOTOPES ; Humans ; IMAGE PROCESSING ; INTERMEDIATE MASS NUCLEI ; IODINE 123 ; IODINE ISOTOPES ; Iodine Radioisotopes ; Iodobenzenes ; ISOTOPES ; Male ; Medical sciences ; MEDICINE ; Middle Aged ; MYOCARDIAL INFARCTION ; Myocardial Infarction - complications ; Myocardial Infarction - diagnostic imaging ; Myocardial Infarction - physiopathology ; NUCLEAR MEDICINE ; NUCLEI ; ODD-EVEN NUCLEI ; ORGANS ; PATIENTS ; PROCESSING ; RADIOISOTOPES ; RADIOLOGY ; RADIOLOGY AND NUCLEAR MEDICINE ; Sympathetic Nervous System - physiopathology ; Thallium Radioisotopes ; TOMOGRAPHY ; Tomography, Emission-Computed ; Ventricular Function, Left</subject><ispartof>The American journal of cardiology, 1991-02, Vol.67 (4), p.236-242</ispartof><rights>1991</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-28bfe88eb70b973d20c04210a892d43dba936d6142dedae57d3cbaf50c2926e73</citedby><cites>FETCH-LOGICAL-c329t-28bfe88eb70b973d20c04210a892d43dba936d6142dedae57d3cbaf50c2926e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/000291499190552V$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19613426$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1990785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/5893962$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>McGhie, A.Iain</creatorcontrib><creatorcontrib>Corbett, James R.</creatorcontrib><creatorcontrib>Akers, Marvin S.</creatorcontrib><creatorcontrib>Kulkarni, Padmakur</creatorcontrib><creatorcontrib>Sills, Michael N.</creatorcontrib><creatorcontrib>Kremers, Mark</creatorcontrib><creatorcontrib>Buja, L.Maximilian</creatorcontrib><creatorcontrib>Durant-Reville, Marc</creatorcontrib><creatorcontrib>Parkey, Robert W.</creatorcontrib><creatorcontrib>Willerson, James T.</creatorcontrib><title>Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>The effect of acute myocardial infarction (AMI) on regional cardiac adrenergic function was studied in 27 patients mean ± standard deviation 10 ± 4 days after AMI. Regional adrenergk function was evaluated noninvasively with I-123 meta-iodobenzylguanidine (MIBG) using a dedicated 3-detector tomograph. Four hours after its administration, there was reduced MIBG uptake in the region of infarction, 0.38 ± 0.31 counts/pixel/mCi × 103 compared with 0.60 ± 0.30 counts/pixel/mCi × 103 and 0.92 ± 0.35 counts/pixel/mCi × 103 in the zones bordering and distant from the infarct area, respectively, p &lt; 0.001. In all patients, the area of reduced MIBG uptake after 4 hours was more extensive than the associated thallium-201 perfusion defect with defect scores of 52 ± 22 and 23 ± 18%, respectively, p &lt; 0.001. After anterior wall AMI, the 4-hour MIBG defect score was 70 ± 13% and the degree of mismatch between myocardial perfusion and MIBG uptake was 30 ± 9% compared with 39 ± 17 and 21 ± 17% after inferior AMI, p &lt; 0.001 and p = 0.016, respectively. The 4-hour MIBG defect score correlated inversely with the predischarge left ventricular ejection fraction, r = −0.73, p &lt; 0.001. Patients with ventricular arrhythmia of ≥1 ventricular premature complexes per hour, paired ventricular premature complexes or ventricular tachycardia detected during the late hospital phase had higher 4-hour MIBG defect scores, 62.5 ± 15.0%, than patients with no detectable complex ventricular ectopic activity and a ventricular premature complex frequency of &lt;1 per hour, 44.6 ± 23.4%, p = 0.036. These data suggest that after acute AMI in humans (1) the abnormality in adrenergic function is more extensive than the associated abnormality in myocardial perfusion; (2) anterior wall AMI is associated with greater disruption of cardiac adrenergic function than other infarcts; (3) the severity of cardiac adrenergic dysfunction correlates with the degree of left ventricular dysfunction; and (4) the abnormality in regional adrenergic function may be associated with the presence of ventricular ectopic activity after AMI.</description><subject>3-Iodobenzylguanidine</subject><subject>550601 - Medicine- Unsealed Radionuclides in Diagnostics</subject><subject>Adult</subject><subject>Aged</subject><subject>Arrhythmias, Cardiac - complications</subject><subject>BETA DECAY RADIOISOTOPES</subject><subject>Biological and medical sciences</subject><subject>BIOMEDICAL RADIOGRAPHY</subject><subject>BODY</subject><subject>Cardiology. Vascular system</subject><subject>CARDIOVASCULAR DISEASES</subject><subject>CARDIOVASCULAR SYSTEM</subject><subject>Catecholamines - blood</subject><subject>COMPUTERIZED TOMOGRAPHY</subject><subject>Contrast Media</subject><subject>Coronary heart disease</subject><subject>DIAGNOSIS</subject><subject>DIAGNOSTIC TECHNIQUES</subject><subject>DISEASES</subject><subject>ELECTRON CAPTURE RADIOISOTOPES</subject><subject>EMISSION COMPUTED TOMOGRAPHY</subject><subject>Female</subject><subject>HEART</subject><subject>HOURS LIVING RADIOISOTOPES</subject><subject>Humans</subject><subject>IMAGE PROCESSING</subject><subject>INTERMEDIATE MASS NUCLEI</subject><subject>IODINE 123</subject><subject>IODINE ISOTOPES</subject><subject>Iodine Radioisotopes</subject><subject>Iodobenzenes</subject><subject>ISOTOPES</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MEDICINE</subject><subject>Middle Aged</subject><subject>MYOCARDIAL INFARCTION</subject><subject>Myocardial Infarction - complications</subject><subject>Myocardial Infarction - diagnostic imaging</subject><subject>Myocardial Infarction - physiopathology</subject><subject>NUCLEAR MEDICINE</subject><subject>NUCLEI</subject><subject>ODD-EVEN NUCLEI</subject><subject>ORGANS</subject><subject>PATIENTS</subject><subject>PROCESSING</subject><subject>RADIOISOTOPES</subject><subject>RADIOLOGY</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>Sympathetic Nervous System - physiopathology</subject><subject>Thallium Radioisotopes</subject><subject>TOMOGRAPHY</subject><subject>Tomography, Emission-Computed</subject><subject>Ventricular Function, Left</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUuLFTEQhYMo452r_0ChERx00ZpHv7IRZPAxMCCIzjZUJ9U9ke7kmqSF68a_bnr6oq5cJCHUd05Spwh5wugrRlnzmlLKS8kq-UKyl5LWNS9v7pEd61pZMsnEfbL7gzwk5zF-y1fG6uaMnDEpadvVO_LrM47WO5gKDcFY0AWYgA7DaHUxLE6nXC2WaN1YXJWMi2LGBKX1xvfofh6ncQFnjXVYJD_7McDhNivtDOMqgSFhKEAvCYv56Lc3psK6AcKd9SPyYIAp4uPTuSdf37_7cvmxvP704ery7XWpBZep5F0_YNdh39JetsJwqmnFGYVOclMJ04MUjWlYxQ0awLo1Qvcw1FRzyRtsxZ4823x9TFZFbRPqW-2dQ51U3UkhG56hiw06BP99wZjUbKPGaQKHfomqo5UQMq89qTZQBx9jwEEdQm45HBWjah2OWpNXa_J5U3fDUTdZ9vTkv_Qzmr-ibRq5_vxUh6hhGgI4beM_WMNExZvMvdk4zIn9sBjWhtBpNDas_Rhv__-R31b8rUw</recordid><startdate>19910201</startdate><enddate>19910201</enddate><creator>McGhie, A.Iain</creator><creator>Corbett, James R.</creator><creator>Akers, Marvin S.</creator><creator>Kulkarni, Padmakur</creator><creator>Sills, Michael N.</creator><creator>Kremers, Mark</creator><creator>Buja, L.Maximilian</creator><creator>Durant-Reville, Marc</creator><creator>Parkey, Robert W.</creator><creator>Willerson, James T.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>19910201</creationdate><title>Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction</title><author>McGhie, A.Iain ; Corbett, James R. ; Akers, Marvin S. ; Kulkarni, Padmakur ; Sills, Michael N. ; Kremers, Mark ; Buja, L.Maximilian ; Durant-Reville, Marc ; Parkey, Robert W. ; Willerson, James T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-28bfe88eb70b973d20c04210a892d43dba936d6142dedae57d3cbaf50c2926e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>3-Iodobenzylguanidine</topic><topic>550601 - Medicine- Unsealed Radionuclides in Diagnostics</topic><topic>Adult</topic><topic>Aged</topic><topic>Arrhythmias, Cardiac - complications</topic><topic>BETA DECAY RADIOISOTOPES</topic><topic>Biological and medical sciences</topic><topic>BIOMEDICAL RADIOGRAPHY</topic><topic>BODY</topic><topic>Cardiology. Vascular system</topic><topic>CARDIOVASCULAR DISEASES</topic><topic>CARDIOVASCULAR SYSTEM</topic><topic>Catecholamines - blood</topic><topic>COMPUTERIZED TOMOGRAPHY</topic><topic>Contrast Media</topic><topic>Coronary heart disease</topic><topic>DIAGNOSIS</topic><topic>DIAGNOSTIC TECHNIQUES</topic><topic>DISEASES</topic><topic>ELECTRON CAPTURE RADIOISOTOPES</topic><topic>EMISSION COMPUTED TOMOGRAPHY</topic><topic>Female</topic><topic>HEART</topic><topic>HOURS LIVING RADIOISOTOPES</topic><topic>Humans</topic><topic>IMAGE PROCESSING</topic><topic>INTERMEDIATE MASS NUCLEI</topic><topic>IODINE 123</topic><topic>IODINE ISOTOPES</topic><topic>Iodine Radioisotopes</topic><topic>Iodobenzenes</topic><topic>ISOTOPES</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MEDICINE</topic><topic>Middle Aged</topic><topic>MYOCARDIAL INFARCTION</topic><topic>Myocardial Infarction - complications</topic><topic>Myocardial Infarction - diagnostic imaging</topic><topic>Myocardial Infarction - physiopathology</topic><topic>NUCLEAR MEDICINE</topic><topic>NUCLEI</topic><topic>ODD-EVEN NUCLEI</topic><topic>ORGANS</topic><topic>PATIENTS</topic><topic>PROCESSING</topic><topic>RADIOISOTOPES</topic><topic>RADIOLOGY</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>Sympathetic Nervous System - physiopathology</topic><topic>Thallium Radioisotopes</topic><topic>TOMOGRAPHY</topic><topic>Tomography, Emission-Computed</topic><topic>Ventricular Function, Left</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McGhie, A.Iain</creatorcontrib><creatorcontrib>Corbett, James R.</creatorcontrib><creatorcontrib>Akers, Marvin S.</creatorcontrib><creatorcontrib>Kulkarni, Padmakur</creatorcontrib><creatorcontrib>Sills, Michael N.</creatorcontrib><creatorcontrib>Kremers, Mark</creatorcontrib><creatorcontrib>Buja, L.Maximilian</creatorcontrib><creatorcontrib>Durant-Reville, Marc</creatorcontrib><creatorcontrib>Parkey, Robert W.</creatorcontrib><creatorcontrib>Willerson, James T.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McGhie, A.Iain</au><au>Corbett, James R.</au><au>Akers, Marvin S.</au><au>Kulkarni, Padmakur</au><au>Sills, Michael N.</au><au>Kremers, Mark</au><au>Buja, L.Maximilian</au><au>Durant-Reville, Marc</au><au>Parkey, Robert W.</au><au>Willerson, James T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>1991-02-01</date><risdate>1991</risdate><volume>67</volume><issue>4</issue><spage>236</spage><epage>242</epage><pages>236-242</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>The effect of acute myocardial infarction (AMI) on regional cardiac adrenergic function was studied in 27 patients mean ± standard deviation 10 ± 4 days after AMI. Regional adrenergk function was evaluated noninvasively with I-123 meta-iodobenzylguanidine (MIBG) using a dedicated 3-detector tomograph. Four hours after its administration, there was reduced MIBG uptake in the region of infarction, 0.38 ± 0.31 counts/pixel/mCi × 103 compared with 0.60 ± 0.30 counts/pixel/mCi × 103 and 0.92 ± 0.35 counts/pixel/mCi × 103 in the zones bordering and distant from the infarct area, respectively, p &lt; 0.001. In all patients, the area of reduced MIBG uptake after 4 hours was more extensive than the associated thallium-201 perfusion defect with defect scores of 52 ± 22 and 23 ± 18%, respectively, p &lt; 0.001. After anterior wall AMI, the 4-hour MIBG defect score was 70 ± 13% and the degree of mismatch between myocardial perfusion and MIBG uptake was 30 ± 9% compared with 39 ± 17 and 21 ± 17% after inferior AMI, p &lt; 0.001 and p = 0.016, respectively. The 4-hour MIBG defect score correlated inversely with the predischarge left ventricular ejection fraction, r = −0.73, p &lt; 0.001. Patients with ventricular arrhythmia of ≥1 ventricular premature complexes per hour, paired ventricular premature complexes or ventricular tachycardia detected during the late hospital phase had higher 4-hour MIBG defect scores, 62.5 ± 15.0%, than patients with no detectable complex ventricular ectopic activity and a ventricular premature complex frequency of &lt;1 per hour, 44.6 ± 23.4%, p = 0.036. These data suggest that after acute AMI in humans (1) the abnormality in adrenergic function is more extensive than the associated abnormality in myocardial perfusion; (2) anterior wall AMI is associated with greater disruption of cardiac adrenergic function than other infarcts; (3) the severity of cardiac adrenergic dysfunction correlates with the degree of left ventricular dysfunction; and (4) the abnormality in regional adrenergic function may be associated with the presence of ventricular ectopic activity after AMI.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>1990785</pmid><doi>10.1016/0002-9149(91)90552-V</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 1991-02, Vol.67 (4), p.236-242
issn 0002-9149
1879-1913
language eng
recordid cdi_osti_scitechconnect_5893962
source MEDLINE; Elsevier ScienceDirect Journals
subjects 3-Iodobenzylguanidine
550601 - Medicine- Unsealed Radionuclides in Diagnostics
Adult
Aged
Arrhythmias, Cardiac - complications
BETA DECAY RADIOISOTOPES
Biological and medical sciences
BIOMEDICAL RADIOGRAPHY
BODY
Cardiology. Vascular system
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
Catecholamines - blood
COMPUTERIZED TOMOGRAPHY
Contrast Media
Coronary heart disease
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
Female
HEART
HOURS LIVING RADIOISOTOPES
Humans
IMAGE PROCESSING
INTERMEDIATE MASS NUCLEI
IODINE 123
IODINE ISOTOPES
Iodine Radioisotopes
Iodobenzenes
ISOTOPES
Male
Medical sciences
MEDICINE
Middle Aged
MYOCARDIAL INFARCTION
Myocardial Infarction - complications
Myocardial Infarction - diagnostic imaging
Myocardial Infarction - physiopathology
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
PROCESSING
RADIOISOTOPES
RADIOLOGY
RADIOLOGY AND NUCLEAR MEDICINE
Sympathetic Nervous System - physiopathology
Thallium Radioisotopes
TOMOGRAPHY
Tomography, Emission-Computed
Ventricular Function, Left
title Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T10%3A27%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regional%20cardiac%20adrenergic%20function%20using%20I-123%20meta-iodobenzylguanidine%20tomographic%20imaging%20after%20acute%20myocardial%20infarction&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=McGhie,%20A.Iain&rft.date=1991-02-01&rft.volume=67&rft.issue=4&rft.spage=236&rft.epage=242&rft.pages=236-242&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/0002-9149(91)90552-V&rft_dat=%3Cproquest_osti_%3E80433943%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80433943&rft_id=info:pmid/1990785&rft_els_id=000291499190552V&rfr_iscdi=true